Royalty Pharma PLCNASDAQ:RPRX
- LAST PRICE28.0000
- TODAY'S CHANGE (%)-0.1100 (-0.3913%)
- Bid / Lots28.0000/ 33
- Ask / Lots28.3200/ 1
- Open / Previous Close27.9800 / 28.1100
- Day Range
- 52 Week Range
- Volume1,748,254
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | RPRX |
|---|---|---|
| 09:32 ET | 11667 | 27.93 |
| 09:34 ET | 1420 | 27.92 |
| 09:36 ET | 500 | 27.85 |
| 09:38 ET | 3430 | 27.96 |
| 09:39 ET | 2387 | 28.02 |
| 09:41 ET | 6016 | 28.07 |
| 09:43 ET | 1847 | 28.1084 |
| 09:45 ET | 2100 | 28.09 |
| 09:48 ET | 1397 | 28.06 |
| 09:50 ET | 1032 | 28.065 |
| 09:52 ET | 738 | 28.071 |
| 09:54 ET | 1064 | 28.11 |
| 09:56 ET | 2489 | 28.16 |
| 09:57 ET | 412 | 28.16 |
| 09:59 ET | 925 | 28.145 |
| 10:01 ET | 624 | 28.21 |
| 10:03 ET | 616 | 28.23 |
| 10:06 ET | 4390 | 28.26 |
| 10:08 ET | 809 | 28.26 |
| 10:10 ET | 1137 | 28.24 |
| 10:12 ET | 400 | 28.24 |
| 10:14 ET | 1275 | 28.2429 |
| 10:15 ET | 600 | 28.24 |
| 10:17 ET | 700 | 28.24 |
| 10:19 ET | 5808 | 28.242 |
| 10:21 ET | 2761 | 28.21 |
| 10:24 ET | 1414 | 28.24 |
| 10:26 ET | 2000 | 28.23 |
| 10:28 ET | 600 | 28.225 |
| 10:30 ET | 1152 | 28.21 |
| 10:32 ET | 3240 | 28.235 |
| 10:33 ET | 1205 | 28.21 |
| 10:35 ET | 2093 | 28.195 |
| 10:37 ET | 3828 | 28.19 |
| 10:39 ET | 500 | 28.185 |
| 10:42 ET | 18769 | 28.205 |
| 10:44 ET | 2417 | 28.2 |
| 10:46 ET | 1956 | 28.19 |
| 10:48 ET | 1600 | 28.125 |
| 10:50 ET | 1056 | 28.145 |
| 10:51 ET | 3694 | 28.165 |
| 10:53 ET | 400 | 28.18 |
| 10:55 ET | 2886 | 28.165 |
| 10:57 ET | 1300 | 28.185 |
| 11:00 ET | 11862 | 28.185 |
| 11:02 ET | 1275 | 28.1619 |
| 11:04 ET | 3015 | 28.135 |
| 11:06 ET | 400 | 28.15 |
| 11:08 ET | 2364 | 28.17 |
| 11:09 ET | 1059 | 28.125 |
| 11:11 ET | 1100 | 28.165 |
| 11:13 ET | 5912 | 28.14 |
| 11:15 ET | 1987 | 28.16 |
| 11:18 ET | 900 | 28.155 |
| 11:20 ET | 2973 | 28.175 |
| 11:22 ET | 2600 | 28.185 |
| 11:24 ET | 625 | 28.18 |
| 11:26 ET | 600 | 28.17 |
| 11:27 ET | 1023 | 28.165 |
| 11:29 ET | 1500 | 28.145 |
| 11:31 ET | 2800 | 28.15 |
| 11:33 ET | 1000 | 28.16 |
| 11:36 ET | 1072 | 28.15 |
| 11:38 ET | 2012 | 28.17 |
| 11:40 ET | 1900 | 28.1801 |
| 11:42 ET | 2422 | 28.18 |
| 11:44 ET | 900 | 28.18 |
| 11:45 ET | 3338 | 28.155 |
| 11:47 ET | 1500 | 28.19 |
| 11:49 ET | 800 | 28.195 |
| 11:51 ET | 927 | 28.19 |
| 11:54 ET | 4347 | 28.17 |
| 11:56 ET | 2755 | 28.1858 |
| 11:58 ET | 805 | 28.195 |
| 12:00 ET | 800 | 28.19 |
| 12:02 ET | 4704 | 28.185 |
| 12:03 ET | 400 | 28.1939 |
| 12:05 ET | 1974 | 28.195 |
| 12:07 ET | 600 | 28.185 |
| 12:09 ET | 993 | 28.205 |
| 12:12 ET | 2809 | 28.2 |
| 12:14 ET | 1913 | 28.19 |
| 12:16 ET | 387 | 28.19 |
| 12:18 ET | 2233 | 28.2 |
| 12:20 ET | 700 | 28.1975 |
| 12:21 ET | 300 | 28.2 |
| 12:23 ET | 2313 | 28.17 |
| 12:25 ET | 2030 | 28.165 |
| 12:27 ET | 1764 | 28.16 |
| 12:30 ET | 600 | 28.155 |
| 12:32 ET | 900 | 28.175 |
| 12:34 ET | 700 | 28.165 |
| 12:36 ET | 969 | 28.17 |
| 12:38 ET | 960 | 28.165 |
| 12:39 ET | 1580 | 28.145 |
| 12:41 ET | 7722 | 28.165 |
| 12:43 ET | 4839 | 28.14 |
| 12:45 ET | 2483 | 28.125 |
| 12:48 ET | 400 | 28.125 |
| 12:50 ET | 100 | 28.13 |
| 12:52 ET | 300 | 28.125 |
| 12:54 ET | 1310 | 28.14 |
| 12:56 ET | 1500 | 28.125 |
| 12:57 ET | 700 | 28.13 |
| 12:59 ET | 4836 | 28.095 |
| 01:01 ET | 1310 | 28.08 |
| 01:03 ET | 1793 | 28.075 |
| 01:06 ET | 2400 | 28.065 |
| 01:08 ET | 887 | 28.065 |
| 01:10 ET | 2102 | 28.085 |
| 01:12 ET | 6223 | 28.095 |
| 01:14 ET | 3790 | 28.115 |
| 01:15 ET | 2736 | 28.12 |
| 01:17 ET | 1787 | 28.125 |
| 01:19 ET | 2675 | 28.145 |
| 01:21 ET | 1196 | 28.16 |
| 01:24 ET | 2208 | 28.165 |
| 01:26 ET | 781 | 28.15 |
| 01:28 ET | 1072 | 28.16 |
| 01:30 ET | 722 | 28.1682 |
| 01:32 ET | 2153 | 28.14 |
| 01:33 ET | 100 | 28.16 |
| 01:35 ET | 1802 | 28.14 |
| 01:37 ET | 149 | 28.145 |
| 01:39 ET | 842 | 28.14 |
| 01:42 ET | 162 | 28.1301 |
| 01:44 ET | 3564 | 28.14 |
| 01:46 ET | 1346 | 28.145 |
| 01:48 ET | 2620 | 28.155 |
| 01:50 ET | 3785 | 28.18 |
| 01:51 ET | 1693 | 28.17 |
| 01:53 ET | 900 | 28.17 |
| 01:55 ET | 200 | 28.18 |
| 01:57 ET | 820 | 28.175 |
| 02:00 ET | 3251 | 28.1675 |
| 02:02 ET | 2601 | 28.18 |
| 02:04 ET | 436 | 28.1863 |
| 02:06 ET | 1599 | 28.185 |
| 02:08 ET | 1900 | 28.2 |
| 02:09 ET | 1106 | 28.2101 |
| 02:11 ET | 600 | 28.2 |
| 02:13 ET | 1704 | 28.205 |
| 02:15 ET | 2467 | 28.22 |
| 02:18 ET | 863 | 28.225 |
| 02:20 ET | 3992 | 28.22 |
| 02:22 ET | 300 | 28.22 |
| 02:24 ET | 5023 | 28.2 |
| 02:26 ET | 1310 | 28.22 |
| 02:27 ET | 800 | 28.23 |
| 02:29 ET | 1200 | 28.22 |
| 02:31 ET | 1639 | 28.2102 |
| 02:33 ET | 1800 | 28.215 |
| 02:36 ET | 984 | 28.22 |
| 02:38 ET | 3005 | 28.205 |
| 02:40 ET | 1800 | 28.22 |
| 02:42 ET | 692 | 28.23 |
| 02:44 ET | 1391 | 28.24 |
| 02:45 ET | 2011 | 28.24 |
| 02:47 ET | 788 | 28.235 |
| 02:49 ET | 2221 | 28.23 |
| 02:51 ET | 8203 | 28.225 |
| 02:54 ET | 4645 | 28.2 |
| 02:56 ET | 1100 | 28.205 |
| 02:58 ET | 989 | 28.21 |
| 03:00 ET | 1509 | 28.22 |
| 03:02 ET | 2794 | 28.215 |
| 03:03 ET | 4325 | 28.217 |
| 03:05 ET | 3500 | 28.17 |
| 03:07 ET | 400 | 28.175 |
| 03:09 ET | 1304 | 28.175 |
| 03:12 ET | 676 | 28.175 |
| 03:14 ET | 2988 | 28.195 |
| 03:16 ET | 3167 | 28.145 |
| 03:18 ET | 2057 | 28.14 |
| 03:20 ET | 2219 | 28.145 |
| 03:21 ET | 1000 | 28.16 |
| 03:23 ET | 3640 | 28.15 |
| 03:25 ET | 2500 | 28.15 |
| 03:27 ET | 2700 | 28.145 |
| 03:30 ET | 1000 | 28.145 |
| 03:32 ET | 10971 | 28.13 |
| 03:34 ET | 2200 | 28.13 |
| 03:36 ET | 60484 | 28.14 |
| 03:38 ET | 1600 | 28.16 |
| 03:39 ET | 10706 | 28.175 |
| 03:41 ET | 7338 | 28.165 |
| 03:43 ET | 177453 | 28.11 |
| 03:45 ET | 6970 | 28.115 |
| 03:48 ET | 21165 | 28.055 |
| 03:50 ET | 11165 | 28.04 |
| 03:52 ET | 24008 | 28.06 |
| 03:54 ET | 16664 | 28.055 |
| 03:56 ET | 50104 | 27.995 |
| 03:57 ET | 38661 | 28 |
| 03:59 ET | 57914 | 28 |
Apr 19, 2024
Royalty Pharma to Announce First Quarter 2024 Financial Results on May 9, 2024, from 8:15AM ET on Friday Apr 19, 2024 by Dow Jones
8:15AM ET on Friday Apr 19, 2024 by Dow Jones
Apr 17, 2024
Royalty Pharma Declares Second Quarter 2024 Dividend, from 8:15AM ET on Wednesday Apr 17, 2024 by Dow Jones
8:15AM ET on Wednesday Apr 17, 2024 by Dow JonesPress Release: Royalty Pharma Declares Second Quarter 2024 Dividend, from 8:15AM ET on Wednesday Apr 17, 2024 by Dow Jones
8:15AM ET on Wednesday Apr 17, 2024 by Dow Jones
Apr 12, 2024
DJ Royalty Pharma Is Maintained at Buy by B of A Securities, from 8:11AM ET on Friday Apr 12, 2024 by Dow Jones
8:11AM ET on Friday Apr 12, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Royalty Pharma PLC | 16.7B | 11.0x | +1.83% |
Amneal Pharmaceuticals Inc | 1.8B | -18.8x | --- |
Catalent Inc | 10.1B | -7.8x | --- |
Jazz Pharmaceuticals PLC | 6.8B | 17.9x | -3.53% |
Mallinckrodt PLC | 1.6M | 0.0x | --- |
Prestige Consumer Healthcare Inc | 3.5B | -42.9x | --- |
Company Information
Royalty Pharma plc is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. The Company collaborates with innovators from academic institutions, research hospitals and non-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. Its portfolio consists of royalties on over 35 commercial products, including Vertex’s Trikafta, GSK’s Trelegy, Roche’s Evrysdi, Johnson & Johnson’s Tremfya, Biogen’s Tysabri and Spinraza, AbbVie and Johnson & Johnson’s Imbruvica, Astellas and Pfizer’s Xtandi, Novartis’ Promacta, Pfizer’s Nurtec ODT and Gilead’s Trodelvy, and 14 development-stage product candidates. Its development-stage product candidates include Aficamten, Ampreloxetine, BCX10013, MK-8189, Ecopipam, Olpasiran, Pelabresib, KarXT, Pelacarsen, Seltorexant, Trontinemab, TEV-'749, Tulmimetostat and Vanzacaftor. Its subsidiaries include Royalty Pharma Holdings Ltd., Royalty Pharma Investments and others.
Contact Information
- Headquarters
- 110 East 59th StreetNEW YORK, NY, United States 10022
- Phone
- 212-883-0200
- Fax
- ---
Executives
- Chairman of the Board, Chief Executive Officer
- Pablo Legorreta
- Vice Chairman, Executive Vice President
- Christopher Hite
- Chief Financial Officer, Executive Vice President
- Terrance Coyne
- Executive Vice President - Investments and Chief Legal Officer
- George Lloyd
- Executive Vice President - Research and Investments
- Marshall Urist
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $16.7B |
|---|---|
Revenue (TTM) | $2.4B |
Shares Outstanding | 597.4M |
Dividend Yield | 3.00% |
Annual Dividend Rate | 0.8400 USD |
Ex-Dividend Date | 05-16-24 |
Pay Date | 06-14-24 |
Beta | 0.47 |
EPS | $2.54 |
Book Value | $14.61 |
P/E Ratio | 11.0x |
Price/Sales (TTM) | 7.1 |
Price/Cash Flow (TTM) | 9.8x |
Operating Margin | 63.37% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
